Highland Capital Management (Tennessee)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-35,827
Closed -$5.25M 349
2019
Q1
$5.25M Buy
+35,827
New +$5.19M 0.4% 76
2016
Q2
Sell
-5,255
Closed -$1.41M 341
2016
Q1
$1.41M Buy
5,255
+113
+2% +$32.3K 0.12% 170
2015
Q4
$1.61M Buy
5,142
+4,992
+3,328% +$1.49M 0.13% 176
2015
Q3
$41K Hold
150
﹤0.01% 395
2015
Q2
$46K Buy
+150
New +$44.7K ﹤0.01% 394

Other funds holding AGN

Highland Capital Management (Tennessee)'s AGN Position: Q2 2019 in Review

Highland Capital Management (Tennessee) sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 35,827 shares — an estimated $5.25M sold.

Highland Capital Management (Tennessee) first reported a position in AGN in Q2 2015 and held it in 5 quarters. The position peaked at $5.25M in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Highland Capital Management (Tennessee) reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 35,827 Allergan plc shares in Q2 2019, an estimated $5.25M.
  • Highland Capital Management (Tennessee) first reported a position in Allergan plc in Q2 2015 and held it in 5 quarters.
  • Highland Capital Management (Tennessee)'s Allergan plc position peaked at $5.25M in Q1 2019.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2019, filed 29 Jul 2019.